IV Solutions Market Size Worth $18.9 Billion By 2028

0
7

SAN FRANCISCO, Feb. 25, 2021 /PRNewswire/ — The global intravenous solutions market size is expected to reach USD 18.9 billion by 2028 according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 7.9% from 2021 to 2028. The growing incidence rate of chronic diseases such as cancer, increase in the number of premature births, and shortage of I.V. solutions in the U.S. are some of the key factors expected to drive the market.

Key suggestions from the report:

  • The Total Parenteral Nutrition (TPN) segment led the segment in terms of revenue share in 2020 owing to its growing applications in the management of chronic diseases
  • The increasing number of surgeries and post-operative nutritional management is a prime factor driving the vitamins and minerals (salt and electrolyte) segment’s growth
  • North America dominated the market with a revenue share of nearly 40.8% in 2020 due to the high usage of IV fluids in the U.S.

Read 114 page research report with ToC on “Intravenous Solutions Market Size, Share & Trends Analysis Report By Type (TPN, PPN), By Nutrients (Carbohydrates, Single Dose Amino Acid Solution, Parenteral Lipid Emulsion), By Region, And Segment Forecasts, 2021 – 2028” at: https://www.grandviewresearch.com/industry-analysis/intravenous-iv-solutions-market

One of the prime areas wherein intravenous (IV) fluids find usage is severe dehydration. Severe dehydration is seen in diseases such as diarrhea, resulting in the depletion of fluids from the body. According to the WHO, in 2017, diarrhea was the second leading cause of death in children under 5 years of age with around 5,25,000 lives lost each year. Intravenous (IV) fluids can play a key role in the treatment and prevention of deaths caused due to the dehydration/fluid loss associated with diarrhea. Other cases where intravenous fluids find application include surgeries and emergency situations.

The ongoing COVID-19 pandemic is expected to have a positive impact on the market. Intensive Care Units (ICU) worldwide are either operating at full capacity or are overcrowded due to the high influx of patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). As per an article published by BBC, in January 2021, critical care wards across England were running in full capacity. Nutritional care is one of the essential elements in managing these patients. This has increased the demand for intravenous (IV) fluids, as many of the patients, especially the elderly population are placed on ventilators and are unable to consume food orally.

Grand View Research has segmented the global IV solutions market based on type, nutrients, and region:

  • Intravenous Solutions Type Outlook (Revenue, USD Million, 2016 – 2028)
    • Total Parenteral Nutrition (TPN)
    • Peripheral Parenteral Nutrition (PPN)
  • Intravenous Solutions Nutrients Outlook (Revenue, USD Million, 2016 – 2028)
    • Carbohydrates
    • Single Dose Amino Acid Solution
    • Vitamins & Minerals (Salt and electrolyte)
    • Parenteral Lipid Emulsion
    • Others
  • Intravenous Solutions Regional Outlook (Revenue, USD Million, 2016 – 2028)
    • North America
    • Europe
      • U.K.
      • Germany
      • France
      • Russia
      • Switzerland
    • Asia Pacific
      • Japan
      • China
      • India
      • Australia
      • South Korea
    • Latin America
    • MEA

List of Key Players of IV Solutions Market

  • Hospira
  • Terumo Corporation
  • B. Braun Melsungen AG
  • Fresenius Kabi
  • Baxter

Find more research reports on Medical Devices Industry, by Grand View Research:

  • U.S. Intravenous Immunoglobulin Market – The U.S. intravenous immunoglobulin (IVIG) market size is expected to reach USD 5.04 billion by 2025, according to a new report by Grand View Research, Inc. The market is estimated to witness a noteworthy CAGR of 6.1% over the forecast period.
  • Parenteral Nutrition Market – Presence of a large number of malnourished children, high natality rate around the globe, increasing premature births, rising occurrence of cancer, which requires administration of vital nutrients to increase hydration, energy, and strength of cancer patients, and rising adoption by healthcare settings for the administration of nutrients in chronically ill geriatric patients are driving the market.
  • Crohn’s Disease Therapeutics Market Growing prevalence of the disease, along with increase in number of pipeline drugs, is expected to be a key factor driving the market. Prevalence of Crohn’s disease has increased in developing countries owing to industrialization, environmental factors such as differences in exposure to sunlight, changes in diet, smoking, and genetic characteristics.

Gain access to Grand View Compass, our BI enabled intuitive market research database of 10,000+ reports

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:

Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com 
Web: https://www.grandviewresearch.com 
Follow Us: LinkedIn | Twitter 

Logo: https://mma.prnewswire.com/media/661327/Grand_View_Research_Logo.jpg

SOURCE Grand View Research, Inc.

LEAVE A REPLY

Please enter your comment!
Please enter your name here